Clinical Trial Update: Nitric Oxide to Treat Pulmonary Embolism [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating nitric oxide for the treatment of pulmonary embolism has been completed with results posted

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Embolism

Drugs mentioned

• Nitric Oxide (nitric oxide)

Snippet

Sponsor: Indiana University School of Medicine | Conditions: Pulmonary Embolism | Phase 2 | Status: COMPLETED | Results posted: 2018-03-29